Effect of antenatal betamethasone administration on Doppler velocimetry of fetal and uteroplacental vessels: a prospective study

References

[1] Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1990;97:11–25.10.1111/j.1471-0528.1990.tb01711.xSuche in Google Scholar

[2] Kelly BA, Lewandowski AJ, Worton SA, Davis EF, Lazdam M, Francis J, et al. Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism. Pediatrics. 2012;129:e1282–90.10.1542/peds.2011-3175Suche in Google Scholar

[3] Rotmensch S, Liberati M, Vishne TH, Celentano C, Ben-Rafael Z, Bellati U. The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomized trial. Acta Obstet Gynecol Scand. 1999;78:493–500.Suche in Google Scholar

[4] Deren O, Karaer C, Onderoglu L, Yigit N, Durukan T, Bahado-Singh RO. The effect of steroids on the biophysical profile and Doppler indices of umbilical and middle cerebral arteries in healthy preterm fetuses. Eur J Obstet Gynecol Reprod Biol. 2001;99:72–6.10.1016/S0301-2115(01)00367-0Suche in Google Scholar

[5] Piazze J, Anceschi MM, Cerekja A, Cosmi E, Meloni P, Alberini A, et al. The combined effect of betamethasone and ritodrine on the middle cerebral artery in low risk third trimester pregnancies. J Perinat Med. 2007;35:135–40.10.1515/JPM.2007.027Suche in Google Scholar

[6] Urban R, Lemancewicz A, Przepieść J, Urban J, Kretowska M. Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal Doppler flow velocity waveforms. Eur J Obstet Gynecol Reprod Biol. 2005;120:170–4.10.1016/j.ejogrb.2004.09.009Suche in Google Scholar

[7] Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet. 1999;353:1404–7.10.1016/S0140-6736(98)08229-4Suche in Google Scholar

[8] Edwards A, Baker LS, Wallace EM. Changes in fetoplacental vessel flow velocity waveforms following maternal administration of betamethasone. Ultrasound Obstet Gynecol. 2002;20:240–4.10.1046/j.1469-0705.2002.00782.xSuche in Google Scholar PubMed

[9] Edwards A, Baker LS, Wallace EM. Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone. Placenta. 2003;24:12–6.10.1053/plac.2002.0874Suche in Google Scholar PubMed

[10] Kähler C, Schleussner E, Möller A, Seewald HJ. Doppler measurements in fetoplacental vessels after maternal betamethasone administration. Fetal Diagn Ther. 2004;19:52–7.10.1159/000074261Suche in Google Scholar PubMed

[11] Nozaki AM, Francisco RP, Fonseca ES, Miyadahira S, Zugaib M. Fetal hemodynamic changes following maternal betamethasone administration in pregnancies with fetal growth restriction and absent end-diastolic flow in the umbilical artery. Acta Obstet Gynecol Scand. 2009;88:350–4.10.1080/00016340902730334Suche in Google Scholar PubMed

[12] Thuring A, Malcus P, Maršál K. Effect of maternal betamethasone on fetal and uteroplacental blood flow velocity waveforms. Ultrasound Obstet Gynecol. 2011;37:668–72.10.1002/uog.8879Suche in Google Scholar

[13] Müller T, Nanan R, Dietl J. Effect of antenatal corticosteroid administration on Doppler flow velocity parameters in pregnancies with absent or reverse end-diastolic flow in the umbilical artery. Acta Obstet Gynecol Scand. 2003;82:794–6.Suche in Google Scholar

[14] Cohlen BJ, Stigter RH, Derks JB, Mulder EJ, Visser GH. Absence of significant hemodynamic changes in the fetus following maternal betamethasone administration. Ultrasound Obstet Gynecol. 1996;8:252–5.10.1046/j.1469-0705.1996.08040252.xSuche in Google Scholar

[15] Senat MV, Ville Y. Effect of steroids on arterial Doppler in intrauterine growth retardation fetuses. Fetal Diagn Ther. 2000;15:36–40.10.1159/000020972Suche in Google Scholar

[16] Simchen MJ, Alkazaleh F, Adamson SL, Windrim R, Telford J, Beyene J, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2004;190:296–304.10.1016/j.ajog.2003.08.011Suche in Google Scholar

[17] Wijnberger LD, Bilardo CM, Hecher K, Stigter RH, Visser GH. Antenatal betamethasone and fetoplacental blood flow. Lancet. 1999;354:256.10.1016/S0140-6736(05)66329-5Suche in Google Scholar

[18] Piazze JJ, Anceschi MM, La Torre R, Amici F, Maranghi L, Cosmi EV. Effect of antenatal betamethasone therapy on maternal-fetal Doppler velocimetry. Early Hum Dev. 2001;60:225–32.10.1016/S0378-3782(00)00120-1Suche in Google Scholar

[19] Chitrit Y, Caubel P, Herrero R, Schwinte AL, Guillaumin D, Boulanger MC. Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms. BJOG. 2000;107:501–7.10.1111/j.1471-0528.2000.tb13269.xSuche in Google Scholar

[20] Wijnberger LD, Bilardo CM, Hecher K, Stigter RH, Visser GH. Effect of antenatal glucocorticoid therapy on arterial and venous blood flow velocity waveforms in severely growth-restricted fetuses. Ultrasound Obstet Gynecol. 2004;23:584–9.10.1002/uog.1052Suche in Google Scholar

[21] Korebrits C, Yu DH, Ramirez MM, Marinoni E, Bocking AD, Challis JR. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br J Obstet Gynaecol. 1998;105:556–61.10.1111/j.1471-0528.1998.tb10158.xSuche in Google Scholar

[22] Marinoni E, Korebrits C, Di Iorio R, Cosmi EV, Challis JR. Effect of betamethasone in vivo on placental corticotrophin-releasing hormone in human pregnancy. Am J Obstet Gynecol. 1998;178:770–8.10.1016/S0002-9378(98)70490-9Suche in Google Scholar

[23] Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab. 1995;80:2888–93.Suche in Google Scholar

[24] Challis JR, Matthews SG, Van Meir C, Ramirez MM. Current topic: the placental corticotrophin-releasing hormone-adrenocorticotrophin axis. Placenta. 1995;16:481–502.10.1016/S0143-4004(05)80001-3Suche in Google Scholar

[25] de Kloet ER, Reul JM, Sutanto W. Corticosteroids and the brain. J Steroid Biochem Mol Biol. 1990;37:387–94.10.1016/0960-0760(90)90489-8Suche in Google Scholar

[26] Derks JB, Mulder EJ, Visser GH. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol. 1995;102:40–6.10.1111/j.1471-0528.1995.tb09024.xSuche in Google Scholar PubMed

[27] Barkehall-Thomas A, Thompson M, Baker LS, Edwards A, Wallace EM. Betamethasone associated changes in umbilical artery flow velocity waveforms in multiple pregnancies with umbilical artery absent end diastolic flow. Aust NZ J Obstet Gynaecol. 2003;43:360–3.10.1046/j.0004-8666.2003.00104.xSuche in Google Scholar PubMed

[28] Robertson MC, Murila F, Tong S, Baker LS, Yu VY, Wallace EM. Predicting perinatal outcome through changes in umbilical artery Doppler studies after antenatal corticosteroids in the growth-restricted fetus. Obstet Gynecol. 2009;113:636–40.10.1097/AOG.0b013e318197bf4dSuche in Google Scholar PubMed

[29] Hata T, Hashimoto M, Manabe A, Aoki S, Iida K, Masumura S, et al. Maternal and fetal nitric oxide synthesis is decreased in pregnancies with small for gestational age infants. Hum Reprod. 1998;13:1070–3.10.1093/humrep/13.4.1070Suche in Google Scholar PubMed